Serum Phenytoin (Dilantin) Test at Chughtai Lab

Serum Phenytoin (Dilantin) Test at Chughtai Lab

The Serum Phenytoin (Dilantin) Test is a specialized therapeutic drug monitoring (TDM) laboratory investigation performed to measure the concentration of phenytoin in the blood. Phenytoin, commonly known by its brand name Dilantin, is a potent first-generation antiepileptic drug (AED) widely prescribed for the management of generalized tonic-clonic seizures, complex partial seizures, and the prevention or treatment of seizures during or following neurosurgical procedures. Because phenytoin exhibits a narrow therapeutic index and highly complex, non-linear (zero-order) pharmacokinetics, maintaining precise blood concentrations is critical. The diagnostic value of this test lies in its ability to help clinicians optimize dosage, ensure clinical efficacy, and prevent severe drug-induced toxicity.

Phenytoin works by selectively blocking voltage-gated sodium channels in their inactive state. This action stabilizes neuronal membranes and limits the repetitive, high-frequency firing of action potentials in the central nervous system, thereby preventing the spread of seizure activity. However, because the hepatic enzymes responsible for metabolizing phenytoin—specifically cytochrome P450 enzymes CYP2C9 and CYP2C19—can easily become saturated at standard therapeutic doses, a small increase in dosage can lead to a disproportionately large and unpredictable rise in serum concentration. Conversely, a minor decrease can result in subtherapeutic levels, exposing the patient to breakthrough seizures. Consequently, regular monitoring at Chughtai Lab in Lahore, Pakistan, is essential for safe and effective long-term epilepsy management.

Clinical Procedure: What to Expect

Patient Preparation

Appropriate patient preparation is vital to ensure the accuracy and clinical utility of the Serum Phenytoin (Dilantin) Test. Patients must adhere to the following guidelines prior to sample collection:

• Timing of the Draw: The blood sample is typically collected as a ‘trough’ level, which is drawn immediately before the next scheduled dose of phenytoin is administered. This represents the lowest concentration of the drug in the body. In some clinical scenarios, a ‘peak’ level may be requested, usually collected 2 to 4 hours after oral administration. Patients must consult their referring physician to confirm the exact timing.
• Medication History: Patients must inform the laboratory staff and their physician of all medications, over-the-counter drugs, and herbal supplements they are currently taking. Numerous drugs interact with phenytoin, altering its metabolism and protein-binding capacity.
• Fasting: Routine fasting is generally not required for this test. However, patients should avoid high-fat meals immediately before the blood draw, as lipemia can interfere with certain laboratory assay methodologies.
• Hydration: Maintaining normal hydration is recommended, as dehydration can artificially elevate serum drug concentrations.

During the Procedure

The Serum Phenytoin (Dilantin) Test is performed on a standard venous blood sample. The procedure is quick, safe, and conducted by experienced phlebotomists at Chughtai Lab:

• Patient Positioning: The patient is seated comfortably, and the phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm.
• Sanitization: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (70% isopropyl alcohol) to prevent contamination.
• Venipuncture: A sterile, single-use needle is inserted into the vein. A small volume of blood is collected into a serum separator tube (SST) or a plain red-top tube.
• Post-Collection Care: Once the sample is collected, the needle is gently withdrawn, and a sterile cotton swab is pressed against the puncture site to control minor bleeding. A bandage is applied, and the patient is advised to keep pressure on the site for a few minutes.
• Safety and Duration: The entire venipuncture process takes less than five minutes. Risks are minimal and limited to temporary mild discomfort, slight bruising, or extremely rare localized infection at the puncture site.

When is a Serum Phenytoin (Dilantin) Test Performed?

1. Initiation and Titration of Phenytoin Therapy

When a patient is first prescribed phenytoin, a baseline test is performed after steady-state concentration is achieved, which typically takes 5 to 10 days of consistent dosing. This assists the physician in verifying that the initial dosage has successfully achieved a therapeutic concentration within the target range, minimizing the risk of early-onset side effects or early treatment failure.

2. Suspected Phenytoin Toxicity

Physicians request this test immediately if a patient exhibits clinical signs of phenytoin toxicity. Symptoms of toxicity are highly dose-dependent and primarily affect the central nervous system. Common clinical indicators include nystagmus (involuntary eye movement), ataxia (loss of coordination), slurred speech, confusion, severe lethargy, nausea, and cognitive impairment. The test confirms whether these symptoms are due to elevated drug levels.

3. Breakthrough Seizure Activity

If a patient experiences a seizure while taking a prescribed dose of phenytoin, a serum level test is crucial. This helps determine whether the breakthrough seizure is due to subtherapeutic drug levels (which may result from poor patient compliance, rapid drug metabolism, or drug-drug interactions) or if the patient’s seizure disorder has become refractory to the current treatment regimen.

4. Monitoring Drug-Drug Interactions

Phenytoin is highly protein-bound (approximately 90% to albumin) and is metabolized by the hepatic cytochrome P450 system. Consequently, introducing or discontinuing other medications—such as valproic acid, carbamazepine, amiodarone, cimetidine, or certain antibiotics—can drastically alter phenytoin levels. The test is performed to monitor and adjust doses during polytherapy.

5. Physiological Changes and Special Populations

Physiological changes can significantly alter phenytoin pharmacokinetics. This test is frequently performed in pregnant patients (due to increased clearance and volume of distribution), elderly patients (due to reduced hepatic metabolism), and patients with chronic kidney disease or liver impairment. In these populations, total phenytoin levels may appear normal while the active ‘free’ fraction is dangerously elevated.

What Does a Serum Phenytoin (Dilantin) Test Detect?

The Serum Phenytoin (Dilantin) Test detects and quantifies the concentration of the drug in the patient’s blood. Specifically, the laboratory analysis can identify the following clinical states and physiological findings:

• Therapeutic Concentration: A total phenytoin level within the standard therapeutic range of 10 to 20 mcg/mL, indicating optimal seizure control with minimal side effects.
• Subtherapeutic Concentration: A total level below 10 mcg/mL, indicating an insufficient amount of drug to prevent seizures, often due to non-compliance or rapid metabolism.
• Mild Toxicity: Total levels between 20 and 30 mcg/mL, which frequently correlate with lateral gaze nystagmus.
• Moderate Toxicity: Total levels between 30 and 40 mcg/mL, typically associated with ataxia, slurred speech, and progressive coordination difficulties.
• Severe Toxicity: Total levels exceeding 40 mcg/mL, which can cause severe lethargy, confusion, stupor, and paradoxical increases in seizure frequency.
• Extreme Toxicity: Total levels above 50 mcg/mL, which are life-threatening and can lead to coma, respiratory depression, and cardiovascular instability.
• Hypoalbuminemia Effects: Low serum albumin levels (common in malnutrition, liver disease, or nephrotic syndrome) which lead to an increased fraction of active, unbound (free) phenytoin.
• Uremia-Induced Displacement: Altered protein binding in patients with renal failure, where accumulated organic acids displace phenytoin from albumin, raising free drug levels.
• Enzyme Induction: Decreased phenytoin levels caused by co-administered drugs that induce hepatic enzymes (e.g., rifampin, phenobarbital).
• Enzyme Inhibition: Elevated phenytoin levels caused by co-administered drugs that inhibit hepatic enzymes (e.g., fluconazole, omeprazole).
• Patient Non-Adherence: Extremely low or undetectable drug levels in patients prescribed standard therapeutic doses.
• Poor CYP2C9 Metabolism: Unusually high serum levels on low standard doses, suggesting genetic polymorphisms that reduce metabolic capacity.
• Ultra-Rapid Metabolism: Unusually low serum levels despite high daily doses, indicating rapid metabolic clearance.
• Pregnancy Clearance: Decreasing serum concentrations during pregnancy due to increased renal and hepatic clearance.
• Formulation Inequivalence: Fluctuations in drug levels when switching between different generic formulations of phenytoin.
• Malabsorption: Subtherapeutic levels resulting from gastrointestinal disorders that impair drug absorption.
• Drug Displacement by Salicylates: Elevated free phenytoin levels due to displacement from protein-binding sites by high-dose aspirin.
• Valproic Acid Interaction: Displacement of phenytoin from albumin combined with inhibition of its metabolism, leading to complex changes in free and total levels.
• Steady-State Verification: Confirmation that the drug has reached a stable, therapeutic concentration after dose adjustments.
• Acute Overdose: Massive elevation of serum phenytoin following accidental or intentional acute ingestion.

Turnaround Time and Report Access at Chughtai Lab

At Chughtai Lab, we understand that timely diagnostic results are critical for effective clinical decision-making and patient peace of mind. The Serum Phenytoin (Dilantin) Test is processed using state-of-the-art automated immunoassay platforms to ensure maximum accuracy and rapid turnaround. Typically, reports are verified and made available within 12 to 24 hours of sample collection.

Patients can easily access their diagnostic reports online through the official Chughtai Lab website or via the user-friendly My Chughtai Mobile App. Additionally, reports can be received directly via WhatsApp, or collected in person from any of our convenient collection centers located across Lahore and other major cities in Pakistan. Automated SMS alerts are sent to patients as soon as their results are ready.

Serum Phenytoin (Dilantin) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Total Phenytoin Level (Adults)	10.0 – 20.0 mcg/mL	< 10.0 mcg/mL (Subtherapeutic); > 20.0 mcg/mL (Toxic)
Total Phenytoin Level (Pediatrics)	8.0 – 15.0 mcg/mL (may vary by age)	< 8.0 mcg/mL (Subtherapeutic); > 20.0 mcg/mL (Toxic)
Free (Unbound) Phenytoin Level	1.0 – 2.0 mcg/mL (approx. 10% of total)	< 1.0 mcg/mL (Subtherapeutic); > 2.0 mcg/mL (Toxic, even with normal total)
Serum Albumin Level	3.5 – 5.0 g/dL	< 3.5 g/dL (Increases active free phenytoin fraction)
Renal Function (Creatinine / BUN)	Normal range based on age/gender	Impaired renal function (displaces phenytoin from albumin)
Hepatic Enzymes (ALT / AST)	Normal range based on age/gender	Elevated enzymes (may indicate impaired drug metabolism)
Drug Adherence Indicator	Stable therapeutic levels over time	Fluctuating or undetectable levels (suggests non-compliance)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum Phenytoin (Dilantin) Test?

• Experienced Healthcare Professionals: Our pathology laboratory is staffed by highly qualified pathologists, clinical chemists, and skilled laboratory technologists.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the diagnostic process.
• Quality Diagnostic Services: Chughtai Lab utilizes advanced, fully automated immunoassay analyzers to deliver highly precise and reproducible results.
• Professional Reporting: Our reports are structured clearly, incorporating reference ranges and clinical notes to assist referring physicians.
• Modern Diagnostic Approach: We continuously update our laboratory protocols in accordance with international standards and guidelines.
• Comfortable Environment: Our collection centers are designed to provide a clean, hygienic, and welcoming atmosphere for all patients.
• Convenient Location: With an extensive network of collection centers across Lahore and Pakistan, finding a facility near you is effortless.
• Commitment to Accurate Diagnosis: We implement strict internal and external quality control measures to ensure every test result is accurate and reliable.